"Russia Pricing and Reimbursement" now Available at Fast Market Research

Fast Market Research recommends "Russia Pricing and Reimbursement" from Datamonitor, now available

by Bill Thompson

(WireNews+Co) - Boston, MA - 21 March 2013

The Russian pharmaceutical market has shown impressive growth rates over the last few years; despite its ups and downs, the reimbursement program - introduced in 2005 - has been a key driver of this growth. However, the reimbursement system in Russia is fragmented, with regional authorities creating their own lists, making market access especially complex.

Report Scope

- Assess how plans for extending reimbursement to new categories of beneficiaries could impact the Russian market.
- Evaluate what impact price controls have had on the Russian pharma market.

View Full Report Details (http://www.fastmr.com/prod/546444_russia_pricing_and_reimbursement.aspx?afid=201) (http://www.fastmr.com/prod/546444_russia_pricing_and_reimbursement.aspx?afid=201)

Report Hightlights

In January 2010, price controls were imposed on drugs that were included on the Vital and Essential Drugs List (VEDL) with manufacturers having to register their prices with the government and a reference pricing system used to determine the price. Also, wholesaler and pharmacy mark-ups are regulated with regional maximum mark-up ceilings.

Under current proposals for the reimbursement system expansion, some sectors of the population will benefit from full reimbursement, while others will have the cost of their drugs partially reimbursed. Providing sufficient funding is allocated, the expansion could drive future market growth, although it may bring with it greater price controls.

Reasons to Get this Report

- What coverage is provided by the drug reimbursement program in Russia and what is the participation of multinationals in the program?
- How could the recent changes in the drug procurement process impact multinational pharma companies?

Report Table of Contents:

Table of Contents
Overview
Executive Summary
Russia Pricing and Reimbursement Tools
Russia Pricing and Reimbursement Tools
Pricing Issues
Prices of drugs on the Vital and Essential Drug List have been controlled since 2010
Vital and Essential Drug List expanded in 2012
Impact of price controls
Reimbursement Issues
The reimbursement program was introduced in 2005 and split into two subprograms in 2008
Drugs used during in-patient stays in hospitals are reimbursed
Drug procurement processes
Bibliography

Fast Market Research (http://www.fastmr.com?afid=201) is an online aggregator and distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff will help you find the right research to fit your requirements and your budget.  For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156.